Purinergic signaling, dyslipidemia and inflammatory disease (Q38055327)

27 August 2017

title

Purinergic signaling, dyslipidemia and inflammatory disease (English)

1 reference

27 August 2017

1 reference

Daniel L Sparks

1

1 reference

27 August 2017

Cynthia Chatterjee

series ordinal

2

1 reference

27 August 2017

publication date

23 October 2012

1 reference

Cellular Physiology and Biochemistry

27 August 2017

published in

1 reference

27 August 2017

volume

30

1 reference

27 August 2017

issue

6

1 reference

27 August 2017

page(s)

1333-1339

1 reference

Extracellular ATP and ADP activate transcription factor NF-kappa B and induce endothelial cell apoptosis

27 August 2017

cites work

1 reference

P2 receptors: new potential players in atherosclerosis

21 January 2018

1 reference

Extracellular nucleotides as negative modulators of immunity

21 January 2018

1 reference

CD39 and control of cellular immune responses

21 January 2018

1 reference

P2 receptors in cardiovascular regulation and disease

21 January 2018

1 reference

Extracellular ATP in the immune system: more than just a "danger signal".

21 January 2018

1 reference

Mechanisms of ATP release and signalling in the blood vessel wall

21 January 2018

1 reference

P2 receptors and extracellular ATP: a novel homeostatic pathway in inflammation

21 January 2018

1 reference

Inhibition of nitrobenzylthioinosine-sensitive adenosine transport by elevated D-glucose involves activation of P2Y2 purinoceptors in human umbilical vein endothelial cells.

21 January 2018

1 reference

Purinergic modulation of mesangial extracellular matrix production: role in diabetic and other glomerular diseases

21 January 2018

1 reference

High glucose activates nuclear factor of activated T cells in native vascular smooth muscle

21 January 2018

1 reference

Impact of ectoenzymes on p2 and p1 receptor signaling.

21 January 2018

1 reference

Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity

21 January 2018

1 reference

Adenosine-5'-O-(2-thiodiphosphate) is a potent agonist at P2 purinoceptors mediating insulin secretion from perfused rat pancreas

21 January 2018

1 reference

P2 receptor agonists stimulate insulin release from human pancreatic islets

21 January 2018

1 reference

Statins and ATP regulate nuclear pAkt via the P2X7 purinergic receptor in epithelial cells

21 January 2018

1 reference

Extracellular nucleotides inhibit insulin receptor signaling, stimulate autophagy and control lipoprotein secretion

21 January 2018

1 reference

ADP receptor P2Y(13) induce apoptosis in pancreatic beta-cells

21 January 2018

1 reference

ADP mediates inhibition of insulin secretion by activation of P2Y13 receptors in mice

21 January 2018

1 reference

Evidence for nucleotide receptor modulation of cross talk between MAP kinase and NF-kappa B signaling pathways in murine RAW 264.7 macrophages

21 January 2018

1 reference

P2X receptors as cell-surface ATP sensors in health and disease

21 January 2018

1 reference

A new generation of antiplatelet agents

21 January 2018

1 reference

Receptor-mediated pathways of endothelium activity in experimental atherosclerosis.

21 January 2018

1 reference

Oral antiplatelet therapy for acute coronary syndromes: aspirin, P2Y12 inhibition and thrombin receptor antagonists

21 January 2018

1 reference

Blood platelet reactivity and its pharmacological modulation in (people with) diabetes mellitus

21 January 2018

1 reference

Defective P2Y purinergic receptor function: A possible novel mechanism for impaired glucose transport.

21 January 2018

1 reference

Enhanced P2X7 activity in human fibroblasts from diabetic patients: a possible pathogenetic mechanism for vascular damage in diabetes

21 January 2018

1 reference

Expression and function of P2X(7) receptor and CD39/Entpd1 in patients with type 2 diabetes and their association with biochemical parameters.

21 January 2018

1 reference

Adipocyte P2X7 receptors expression: a role in modulating inflammatory response in subjects with metabolic syndrome?

21 January 2018

1 reference

Functional ENTPD1 polymorphisms in African Americans with diabetes and end-stage renal disease

21 January 2018

1 reference

Deletion of cd39/entpd1 results in hepatic insulin resistance

21 January 2018

1 reference

Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis

21 January 2018

1 reference

Stimulation of cell surface F1-ATPase activity by apolipoprotein A-I inhibits endothelial cell apoptosis and promotes proliferation.

21 January 2018

1 reference

The nucleotide receptor P2Y13 is a key regulator of hepatic high-density lipoprotein (HDL) endocytosis.

21 January 2018

1 reference

Cell surface adenylate kinase activity regulates the F(1)-ATPase/P2Y (13)-mediated HDL endocytosis pathway on human hepatocytes.

21 January 2018

1 reference

Mitochondrial inhibitory factor 1 (IF1) is present in human serum and is positively correlated with HDL-cholesterol

21 January 2018

1 reference

Niacin inhibits surface expression of ATP synthase beta chain in HepG2 cells: implications for raising HDL.

21 January 2018

1 reference

An induction in hepatic HDL secretion associated with reduced ATPase expression

21 January 2018

1 reference

Apolipoprotein B is intracellularly associated with an ER-60 protease homologue in HepG2 cells

21 January 2018

1 reference

Mechanisms targeting apolipoprotein B100 to proteasomal degradation: evidence that degradation is initiated by BiP binding at the N terminus and the formation of a p97 complex at the C terminus

21 January 2018

1 reference

Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability

21 January 2018

1 reference

Induction of autophagy by proteasome inhibitor is associated with proliferative arrest in colon cancer cells.

21 January 2018

1 reference

Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells

21 January 2018

1 reference

Macroautophagy and ERK phosphorylation counteract the antiproliferative effect of proteasome inhibitor in gastric cancer cells.

21 January 2018

1 reference

Autophagy and the Integrated Stress Response

21 January 2018

1 reference

Regulation of mammalian autophagy in physiology and pathophysiology.

21 January 2018

1 reference

Autophagy regulates cholesterol efflux from macrophage foam cells via lysosomal acid lipase

21 January 2018

1 reference

Overview of the P2 receptors

21 January 2018

1 reference

RhoA/ROCK I signalling downstream of the P2Y13 ADP-receptor controls HDL endocytosis in human hepatocytes

21 January 2018

1 reference

Linking ER Stress to Autophagy: Potential Implications for Cancer Therapy.

21 January 2018

1 reference

Internalization of the human nicotinic acid receptor GPR109A is regulated by G(i), GRK2, and arrestin3.

21 January 2018

1 reference

Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells

21 January 2018

1 reference

Glimepiride upregulates eNOS activity and inhibits cytokine-induced NF-kappaB activation through a phosphoinoside 3-kinase-Akt-dependent pathway

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000343322

1 reference

27 August 2017

1 reference